Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 129 of 129 entries
Sorted by: Best Match Show Resources per page
Infectious risk stratification in multiple sclerosis patients receiving immunotherapy.

Annals of clinical and translational neurology

Graf J, Leussink VI, Dehmel T, Ringelstein M, Goebels N, Adams O, MacKenzie CR, Warnke C, Feldt T, Lammerskitten A, Klotz L, Meuth S, Wiendl H, Hartung HP, Aktas O, Albrecht P.
PMID: 29296620
Ann Clin Transl Neurol. 2017 Nov 24;4(12):909-914. doi: 10.1002/acn3.491. eCollection 2017 Dec.

The increasing number of potent treatments for multiple sclerosis warrants screening for infections. To investigate the prevalence of infections in two independent German patient cohorts with multiple sclerosis/neuromyelitis optica spectrum disorders (NMOSD), we performed a retrospective chart review study...

Cite
Graf J, Leussink VI, Dehmel T, et al. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy. Ann Clin Transl Neurol. 2017;4(12):909-914doi: 10.1002/acn3.491.
Graf, J., Leussink, V. I., Dehmel, T., Ringelstein, M., Goebels, N., Adams, O., MacKenzie, C. R., Warnke, C., Feldt, T., Lammerskitten, A., Klotz, L., Meuth, S., Wiendl, H., Hartung, H. P., Aktas, O., & Albrecht, P. (2017). Infectious risk stratification in multiple sclerosis patients receiving immunotherapy. Annals of clinical and translational neurology, 4(12), 909-914. https://doi.org/10.1002/acn3.491
Graf, Jonas, et al. "Infectious risk stratification in multiple sclerosis patients receiving immunotherapy." Annals of clinical and translational neurology vol. 4,12 (2017): 909-914. doi: https://doi.org/10.1002/acn3.491
Graf J, Leussink VI, Dehmel T, Ringelstein M, Goebels N, Adams O, MacKenzie CR, Warnke C, Feldt T, Lammerskitten A, Klotz L, Meuth S, Wiendl H, Hartung HP, Aktas O, Albrecht P. Infectious risk stratification in multiple sclerosis patients receiving immunotherapy. Ann Clin Transl Neurol. 2017 Nov 24;4(12):909-914. doi: 10.1002/acn3.491. eCollection 2017 Dec. PMID: 29296620; PMCID: PMC5740259.
Copy Download .nbib Format: NLM
High-Contrast Imaging of Intermediate-Mass Giants with Long-Term Radial Velocity Trends.

The Astrophysical journal

Ryu T, Sato B, Kuzuhara M, Narita N, Takahashi YH, Uyama T, Kudo T, Kusakabe N, Hashimoto J, Omiya M, Harakawa H, Abe L, Ando H, Brandner W, Brandt TD, Carson JC, Currie T, Egner S, Feldt M, Goto M, Grady CA, Guyon O, Hayano Y, Hayashi M, Hayashi SS, Hełminiak KG, Henning T, Hodapp KW, Ida S, Ishii M, Itoh Y, Iye M, Izumiura H, Janson M, Kambe E, Kandori R, Knapp GR, Kokubo E, Kwon J, Matsuo T, Mayama S, McElwain MW, Mede K, Miyama S, Morino JI, Moro-Martin A, Nishimura T, Pyo TS, Serabyn E, Suenaga T, Suto H, Suzuki R, Takami M, Takato N, Takeda Y, Terada H, Thalmann C, Turner EL, Watanabe M, Wisniewski J, Yamada T, Yoshida M, Takami H, Usuda T, Tamura M.
PMID: 32753766
Astrophys J. 2016 Jul 10;825(2). doi: 10.3847/0004-637X/825/2/127. Epub 2016 Jul 12.

A radial velocity (RV) survey for intermediate-mass giants has been operated for over a decade at Okayama Astrophysical Observatory (OAO). The OAO survey has revealed that some giants show long-term linear RV accelerations (RV trends), indicating the presence of...

Cite
Ryu T, Sato B, Kuzuhara M, et al. High-Contrast Imaging of Intermediate-Mass Giants with Long-Term Radial Velocity Trends. Astrophys J. 2016;825(2)doi: 10.3847/0004-637X/825/2/127.
Ryu, T., Sato, B., Kuzuhara, M., Narita, N., Takahashi, Y. H., Uyama, T., Kudo, T., Kusakabe, N., Hashimoto, J., Omiya, M., Harakawa, H., Abe, L., Ando, H., Brandner, W., Brandt, T. D., Carson, J. C., Currie, T., Egner, S., Feldt, M., Goto, M., Grady, C. A., Guyon, O., Hayano, Y., Hayashi, M., Hayashi, S. S., Hełminiak, K. G., Henning, T., Hodapp, K. W., Ida, S., Ishii, M., Itoh, Y., Iye, M., Izumiura, H., Janson, M., Kambe, E., Kandori, R., Knapp, G. R., Kokubo, E., Kwon, J., Matsuo, T., Mayama, S., McElwain, M. W., Mede, K., Miyama, S., Morino, J. I., Moro-Martin, A., Nishimura, T., Pyo, T. S., Serabyn, E., Suenaga, T., Suto, H., Suzuki, R., Takami, M., Takato, N., Takeda, Y., Terada, H., Thalmann, C., Turner, E. L., Watanabe, M., Wisniewski, J., Yamada, T., Yoshida, M., Takami, H., Usuda, T., & Tamura, M. (2016). High-Contrast Imaging of Intermediate-Mass Giants with Long-Term Radial Velocity Trends. The Astrophysical journal, 825(2), . https://doi.org/10.3847/0004-637X/825/2/127
Ryu, Tsuguru, et al. "High-Contrast Imaging of Intermediate-Mass Giants with Long-Term Radial Velocity Trends." The Astrophysical journal vol. 825,2 (2016). doi: https://doi.org/10.3847/0004-637X/825/2/127
Ryu T, Sato B, Kuzuhara M, Narita N, Takahashi YH, Uyama T, Kudo T, Kusakabe N, Hashimoto J, Omiya M, Harakawa H, Abe L, Ando H, Brandner W, Brandt TD, Carson JC, Currie T, Egner S, Feldt M, Goto M, Grady CA, Guyon O, Hayano Y, Hayashi M, Hayashi SS, Hełminiak KG, Henning T, Hodapp KW, Ida S, Ishii M, Itoh Y, Iye M, Izumiura H, Janson M, Kambe E, Kandori R, Knapp GR, Kokubo E, Kwon J, Matsuo T, Mayama S, McElwain MW, Mede K, Miyama S, Morino JI, Moro-Martin A, Nishimura T, Pyo TS, Serabyn E, Suenaga T, Suto H, Suzuki R, Takami M, Takato N, Takeda Y, Terada H, Thalmann C, Turner EL, Watanabe M, Wisniewski J, Yamada T, Yoshida M, Takami H, Usuda T, Tamura M. High-Contrast Imaging of Intermediate-Mass Giants with Long-Term Radial Velocity Trends. Astrophys J. 2016 Jul 10;825(2). doi: 10.3847/0004-637X/825/2/127. Epub 2016 Jul 12. PMID: 32753766; PMCID: PMC7402361.
Copy Download .nbib Format: NLM
Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation.

Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases

Demoliner M, da Silva MS, Gularte JS, Hansen AW, de Almeida PR, Weber MN, Heldt FH, Silveira F, Filippi M, de Abreu Góes Pereira VM, da Silva FP, Mallmann L, Fink P, de Moura Valim AR, Possuelo LG, Fleck JD, Spilki FR.
PMID: 34763050
Infect Genet Evol. 2021 Dec;96:105134. doi: 10.1016/j.meegid.2021.105134. Epub 2021 Nov 09.

Recently, the highest wave of SARS-CoV-2 epidemic occurred since the beginning of the pandemic in Brazil was registered in Rio Grande do Sul (RS) State, Southern Brazil, considering the number of cases, deaths and hospitalization per day caused by...

Cite
Demoliner M, da Silva MS, Gularte JS, et al. Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation. Infect Genet Evol. 2021;96:105134doi: 10.1016/j.meegid.2021.105134.
Demoliner, M., da Silva, M. S., Gularte, J. S., Hansen, A. W., de Almeida, P. R., Weber, M. N., Heldt, F. H., Silveira, F., Filippi, M., de Abreu Góes Pereira, V. M., da Silva, F. P., Mallmann, L., Fink, P., de Moura Valim, A. R., Possuelo, L. G., Fleck, J. D., & Spilki, F. R. (2021). Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 96105134. https://doi.org/10.1016/j.meegid.2021.105134
Demoliner, Meriane, et al. "Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation." Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases vol. 96 (2021): 105134. doi: https://doi.org/10.1016/j.meegid.2021.105134
Demoliner M, da Silva MS, Gularte JS, Hansen AW, de Almeida PR, Weber MN, Heldt FH, Silveira F, Filippi M, de Abreu Góes Pereira VM, da Silva FP, Mallmann L, Fink P, de Moura Valim AR, Possuelo LG, Fleck JD, Spilki FR. Predominance of SARS-CoV-2 P.1 (Gamma) lineage inducing the recent COVID-19 wave in southern Brazil and the finding of an additional S: D614A mutation. Infect Genet Evol. 2021 Dec;96:105134. doi: 10.1016/j.meegid.2021.105134. Epub 2021 Nov 09. PMID: 34763050; PMCID: PMC8575543.
Copy Download .nbib Format: NLM
Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases.

Artificial intelligence in the life sciences

Linden T, Hanses F, Domingo-Fernández D, DeLong LN, Kodamullil AT, Schneider J, Vehreschild MJGT, Lanznaster J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Hertenstein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stecher M, Kuzikov M, Zaliani A, Fröhlich H.
PMID: 34988543
Artif Intell Life Sci. 2021 Dec;1:100020. doi: 10.1016/j.ailsci.2021.100020. Epub 2021 Dec 17.

Despite available vaccinations COVID-19 case numbers around the world are still growing, and effective medications against severe cases are lacking. In this work, we developed a machine learning model which predicts mortality for COVID-19 patients using data from the...

Cite
Linden T, Hanses F, Domingo-Fernández D, et al. Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases. Artif Intell Life Sci. 2021;1:100020doi: 10.1016/j.ailsci.2021.100020.
Linden, T., Hanses, F., Domingo-Fernández, D., DeLong, L. N., Kodamullil, A. T., Schneider, J., Vehreschild, M. J. G. T., Lanznaster, J., Ruethrich, M. M., Borgmann, S., Hower, M., Wille, K., Feldt, T., Rieg, S., Hertenstein, B., Wyen, C., Roemmele, C., Vehreschild, J. J., Jakob, C. E. M., Stecher, M., Kuzikov, M., Zaliani, A., Fröhlich, H. (2021). Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases. Artificial intelligence in the life sciences, 1100020. https://doi.org/10.1016/j.ailsci.2021.100020
Linden, Thomas, et al. "Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases." Artificial intelligence in the life sciences vol. 1 (2021): 100020. doi: https://doi.org/10.1016/j.ailsci.2021.100020
Linden T, Hanses F, Domingo-Fernández D, DeLong LN, Kodamullil AT, Schneider J, Vehreschild MJGT, Lanznaster J, Ruethrich MM, Borgmann S, Hower M, Wille K, Feldt T, Rieg S, Hertenstein B, Wyen C, Roemmele C, Vehreschild JJ, Jakob CEM, Stecher M, Kuzikov M, Zaliani A, Fröhlich H. Machine Learning Based Prediction of COVID-19 Mortality Suggests Repositioning of Anticancer Drug for Treating Severe Cases. Artif Intell Life Sci. 2021 Dec;1:100020. doi: 10.1016/j.ailsci.2021.100020. Epub 2021 Dec 17. PMID: 34988543; PMCID: PMC8677630.
Copy Download .nbib Format: NLM
TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature.

PLoS neglected tropical diseases

Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM.
PMID: 34932562
PLoS Negl Trop Dis. 2021 Dec 21;15(12):e0010065. doi: 10.1371/journal.pntd.0010065. eCollection 2021 Dec.

BACKGROUND: Transjugular intrahepatic portosystemic shunt (TIPS) and shunt surgery are established treatment options for portal hypertension, but have not been systematically evaluated in patients with portal hypertension due to hepatosplenic schistosomiasis (HSS), one of the neglected tropical diseases with...

Cite
Nordmann T, Schlabe S, Feldt T, et al. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS Negl Trop Dis. 2021;15(12):e0010065doi: 10.1371/journal.pntd.0010065.
Nordmann, T., Schlabe, S., Feldt, T., Gobbi, F., Krieg, A., Bode, J. G., Fuchs, A., Kraef, C., Praktiknjo, M., Trebicka, J., Ramharter, M., Addo, M. M., Strassburg, C., Lohse, A. W., Luedde, T., Schmiedel, S., & Orth, H. M. (2021). TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS neglected tropical diseases, 15(12), e0010065. https://doi.org/10.1371/journal.pntd.0010065
Nordmann, Tamara, et al. "TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature." PLoS neglected tropical diseases vol. 15,12 (2021): e0010065. doi: https://doi.org/10.1371/journal.pntd.0010065
Nordmann T, Schlabe S, Feldt T, Gobbi F, Krieg A, Bode JG, Fuchs A, Kraef C, Praktiknjo M, Trebicka J, Ramharter M, Addo MM, Strassburg C, Lohse AW, Luedde T, Schmiedel S, Orth HM. TIPS and splenorenal shunt for complications of portal hypertension in chronic hepatosplenic schistosomiasis-A case series and review of the literature. PLoS Negl Trop Dis. 2021 Dec 21;15(12):e0010065. doi: 10.1371/journal.pntd.0010065. eCollection 2021 Dec. PMID: 34932562; PMCID: PMC8726476.
Copy Download .nbib Format: NLM
The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial.

Cancer & metabolism

Feldt M, Menard J, Rosendahl AH, Lettiero B, Bendahl PO, Belting M, Borgquist S.
PMID: 33292612
Cancer Metab. 2020 Nov 23;8(1):25. doi: 10.1186/s40170-020-00231-8.

BACKGROUND: Deregulated lipid metabolism is common in cancer cells and the mevalonate pathway, which synthesizes cholesterol, is central in lipid metabolism. This study aimed to assess statin-induced changes of the intratumoral levels of cholesterol and the expression of the...

Cite
Feldt M, Menard J, Rosendahl AH, et al. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial. Cancer Metab. 2020;8(1):25doi: 10.1186/s40170-020-00231-8.
Feldt, M., Menard, J., Rosendahl, A. H., Lettiero, B., Bendahl, P. O., Belting, M., & Borgquist, S. (2020). The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial. Cancer & metabolism, 8(1), 25. https://doi.org/10.1186/s40170-020-00231-8
Feldt, Maria, et al. "The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial." Cancer & metabolism vol. 8,1 (2020): 25. doi: https://doi.org/10.1186/s40170-020-00231-8
Feldt M, Menard J, Rosendahl AH, Lettiero B, Bendahl PO, Belting M, Borgquist S. The effect of statin treatment on intratumoral cholesterol levels and LDL receptor expression: a window-of-opportunity breast cancer trial. Cancer Metab. 2020 Nov 23;8(1):25. doi: 10.1186/s40170-020-00231-8. PMID: 33292612; PMCID: PMC7682108.
Copy Download .nbib Format: NLM
Methanol oxidation on Au(332): an isothermal pulsed molecular beam study.

Physical chemistry chemical physics : PCCP

Feldt CD, Gimm T, Moreira R, Riedel W, Risse T.
PMID: 34558565
Phys Chem Chem Phys. 2021 Oct 06;23(38):21599-21605. doi: 10.1039/d1cp03436g.

Isothermal molecular beam experiments on the methanol oxidation over the stepped Au(332) surface were conducted under well-defined ultra-high vacuum conditions. In the measurements, a continuous flux of methanol at excess in the gas phase and pulses of atomic oxygen...

Cite
Feldt CD, Gimm T, Moreira R, et al. Methanol oxidation on Au(332): an isothermal pulsed molecular beam study. Phys Chem Chem Phys. 2021;23(38):21599-21605doi: 10.1039/d1cp03436g.
Feldt, C. D., Gimm, T., Moreira, R., Riedel, W., & Risse, T. (2021). Methanol oxidation on Au(332): an isothermal pulsed molecular beam study. Physical chemistry chemical physics : PCCP, 23(38), 21599-21605. https://doi.org/10.1039/d1cp03436g
Feldt, Christoph D, et al. "Methanol oxidation on Au(332): an isothermal pulsed molecular beam study." Physical chemistry chemical physics : PCCP vol. 23,38 (2021): 21599-21605. doi: https://doi.org/10.1039/d1cp03436g
Feldt CD, Gimm T, Moreira R, Riedel W, Risse T. Methanol oxidation on Au(332): an isothermal pulsed molecular beam study. Phys Chem Chem Phys. 2021 Oct 06;23(38):21599-21605. doi: 10.1039/d1cp03436g. PMID: 34558565.
Copy Download .nbib Format: NLM
Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis.

The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses

Bow EJ, Pater JL, Louie TJ, Feld R, Mandell L, Robson HG, Chow A, Belch A, Miedzinski L, Paul N, Elliott CR, Willan AR.
PMID: 22416197
Can J Infect Dis. 1992 Sep;3(5):235-9. doi: 10.1155/1992/286453.

In the course of a multicentre clinical trial evaluating two antibacterial regimens for the empiric treatment of suspected infection in febrile neutropenic cancer patients, a suboptimal response was noted among recipients of antibacterial prophylaxis with trimethoprim/sulphamethoxazole (TMP/SMX). Multivariate analysis...

Cite
Bow EJ, Pater JL, Louie TJ, et al. Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis. Can J Infect Dis. 1992;3(5):235-9doi: 10.1155/1992/286453.
Bow, E. J., Pater, J. L., Louie, T. J., Feld, R., Mandell, L., Robson, H. G., Chow, A., Belch, A., Miedzinski, L., Paul, N., Elliott, C. R., & Willan, A. R. (1992). Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis. The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses, 3(5), 235-9. https://doi.org/10.1155/1992/286453
Bow, E J, et al. "Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis." The Canadian journal of infectious diseases = Journal canadien des maladies infectieuses vol. 3,5 (1992): 235-9. doi: https://doi.org/10.1155/1992/286453
Bow EJ, Pater JL, Louie TJ, Feld R, Mandell L, Robson HG, Chow A, Belch A, Miedzinski L, Paul N, Elliott CR, Willan AR. Reduction in clinical response to empiric antimicrobial therapy of febrile granulocytopenic patients receiving TMP/SMX infection prophylaxis. Can J Infect Dis. 1992 Sep;3(5):235-9. doi: 10.1155/1992/286453. PMID: 22416197; PMCID: PMC3298065.
Copy Download .nbib Format: NLM
Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing.

European journal of medical research

Fischer JC, Schmidt AG, Bölke E, Keitel V, Feldt T, Jensen B, Freise NF, Häussinger D, Schneider EM, Hermsen D, Kindgen-Milles D, Knoefel WT, Haussmann J, Tamaskovics B, Plettenberg C, Scheckenbach K, Corradini S, Rox J, Balz V, Maas K, Schmidt L, Grebe O, Ehrhardt A, Gerber PA, Peiper M, Buhren BA, Lichtenberg A, Rezazadeh A, Budach W, Matuschek C.
PMID: 34517930
Eur J Med Res. 2021 Sep 13;26(1):104. doi: 10.1186/s40001-021-00574-y.

No abstract available.

Cite
Fischer JC, Schmidt AG, Bölke E, et al. Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021;26(1):104doi: 10.1186/s40001-021-00574-y.
Fischer, J. C., Schmidt, A. G., Bölke, E., Keitel, V., Feldt, T., Jensen, B., Freise, N. F., Häussinger, D., Schneider, E. M., Hermsen, D., Kindgen-Milles, D., Knoefel, W. T., Haussmann, J., Tamaskovics, B., Plettenberg, C., Scheckenbach, K., Corradini, S., Rox, J., Balz, V., Maas, K., Schmidt, L., Grebe, O., Ehrhardt, A., Gerber, P. A., Peiper, M., Buhren, B. A., Lichtenberg, A., Rezazadeh, A., Budach, W., & Matuschek, C. (2021). Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. European journal of medical research, 26(1), 104. https://doi.org/10.1186/s40001-021-00574-y
Fischer, Johannes C, et al. "Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing." European journal of medical research vol. 26,1 (2021): 104. doi: https://doi.org/10.1186/s40001-021-00574-y
Fischer JC, Schmidt AG, Bölke E, Keitel V, Feldt T, Jensen B, Freise NF, Häussinger D, Schneider EM, Hermsen D, Kindgen-Milles D, Knoefel WT, Haussmann J, Tamaskovics B, Plettenberg C, Scheckenbach K, Corradini S, Rox J, Balz V, Maas K, Schmidt L, Grebe O, Ehrhardt A, Gerber PA, Peiper M, Buhren BA, Lichtenberg A, Rezazadeh A, Budach W, Matuschek C. Correction to: Informed consent and informed intervention: SARS‑CoV‑2 vaccinations not just call for disclosure of newly emerging safety data but also for hypothesis generation and testing. Eur J Med Res. 2021 Sep 13;26(1):104. doi: 10.1186/s40001-021-00574-y. PMID: 34517930; PMCID: PMC8436013.
Copy Download .nbib Format: NLM
Showing 121 to 129 of 129 entries